Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Articles & Analysis
Full List of CADENA Act Recommendations from Resource Speakers at Second Senate Hearing
BitRSS
The 65-Month Clock Is Ticking: Why Bitcoin May Drop 20% While Silver Shines
BeInCrypto
Senators introduce bill to move crypto market regulation from SEC to CFTC
BitRSS
Senators introduce bill to move crypto market regulation from SEC to CFTC
CryptoBriefing
Ethereum Derivatives Heating Up: Open Interest Registers 10% Spike
BitCoinist
Crypto.com Partners with Sui Foundation to Enhance SUI Token Custody and Liquidity Solutions
BitRSS